Coumarin-induced hepatic necrosis

American Journal of Gastroenterology

Volumn 92, Issue 2, 1997, Pages 348-349

  Ghosh, Prodyot ^a   Markin, Rodney S ^a   Sorrell, Michael F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COUMARIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; HUMAN; LIVER NECROSIS; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

AGED; ANTINEOPLASTIC AGENTS; BIOPSY; COUMARINS; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; NECROSIS; PROSTATIC NEOPLASMS;

EID: 0031050781     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Marshall ME, Mohler JO, Edmonds K, et al. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxy coumarin. J Cancer Res Clin Oncol 1994;120(suppl 3):S39.
2. Marshall ME, Kervin K, Benefield C, et al. Growth inhibitory effects of coumarin and 7-hydroxy coumarin on human malignant cell lines in vitro. J Cancer Res Clin Oncol 1994;120(suppl 3).
3. Mohler JL, Williams BT, Thompson IM, et al. Coumarin for the treatment of prostate carcinoma. J Cancer Fies Clin Oncol 1994;120(suppl 3):S35.
4. Fentem JH, Fry JR. Species differences in the metabolism and hepato-toxicity of coumarin. Comp Biochem Physiol 1993;104:1.
5. Cox D, O'Kennedy R, Thornes RD. Rarity of liver toxicity in patients treated with coumarin. Human Toxicol 1989;8:501.